VTVT News and Press, vTv Therapeutics Inc. From 09/04/19

HIGH POINT, N.C., Sept. 04, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for diabetes and Alzheimer’s disease, today announced that it is scheduled to present...

HIGH POINT, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for diabetes and Alzheimer’s disease, today announced that it will be pa...

vTv Therapeutics (NASDAQ: VTVT ): Q2 GAAP EPS of -$0.10 misses by $0.05 . More news on: vTv Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HIGH POINT, N.C., July 31, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second quarter that ended June 30, 2019, and provided an update on recent achievements and upcoming events. “We made significant progress during the ...

Immuron (NASDAQ: IMRN ) +134%  on revenue surge . More news on: Immuron Limited, Neovasc Inc., Bio-Path Holdings, Inc., Stocks on the move, Read more ...

VTv Therapeutics (NASDAQ: VTVT ) has risen 8.8% postmarket after it says it will present at this week's Alzheimer's Association International Conference. More news on: vTv Therapeutics Inc., Healthcare stocks news, Stocks on the move, Read more ...

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered treatments for Alzheimer’s disease and diabetes, today announced that it will make an oral presentation at the 2019 Alzheimer's Association...

Vislink Technologies (NASDAQ: VISL ) +265%  on $2.8M contract . More news on: Vislink Technologies, Inc., Valeritas Holdings, Inc., Harmonic Inc., Stocks on the move, Read more ...

vTv Therapeutics (NASDAQ: VTVT )  falls 2.1%  in after-hours trading after a filing discloses a planned stock offering of 16.45M shares of class A common stock by its principal equity holder, Ronald O. Perelman's MacAndrews & Forbes Group. More news on: vTv Therapeutics Inc...

InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...